Report
أعرض في EDS

Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia (MPOX-COL)

التفاصيل البيبلوغرافية
العنوان: Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia (MPOX-COL)
المؤلفون: Ministerio de Salud y Protección Social de Colombia, Ministry of Health, Labour and Welfare, Japan, Japan Agency for Medical Research and Development, National Center for Global Health and Medicine, Japan, National Institute of Infectious Disease, Japan, Instituto Nacional de Salud
المصدر: Randomized Trial to Evaluate the Efficacy/Effectiveness, Safety, and Immunogenicity of Replicative Live Attenuated Vaccinia Virus Vaccine LC16m8 for Prevention Against Mpox in High-risk Populations During Vaccination Deployment in Colombia
Adnan N, Haq ZU, Malik A, Mehmood A, Ishaq U, Faraz M, Malik J, Mehmoodi A. Human monkeypox virus: An updated review. Medicine (Baltimore). 2022 Sep 2;101(35):e30406. doi: 10.1097/MD.0000000000030406.
Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, Smajlovic S, Cordic S, Rabaan AA, Alsuhaimi E. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023 Apr;16(4):531-541. doi: 10.1016/j.jiph.2023.02.003. Epub 2023 Feb 9.
Mitja O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, Orkin CM. Monkeypox. Lancet. 2023 Jan 7;401(10370):60-74. doi: 10.1016/S0140-6736(22)02075-X. Epub 2022 Nov 17. Erratum In: Lancet. 2022 Dec 3;400(10367):1926. doi: 10.1016/S0140-6736(22)02414-X.
Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004 Jan;4(1):15-25. doi: 10.1016/s1473-3099(03)00856-9. Erratum In: Lancet Infect Dis. 2004 Apr;4(4):251.
Shchelkunov SN, Marennikova SS, Moyer RW. Orthopoxviruses pathogenic for humans: Springer Science & Business Media; 2006.
McInnes et al. Family: Poxviridae [Website]. International Committee on Taxonomy of Viruses (ICTV); 2023 [updated 2023/04/17.
Parker S, Buller RM. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Future Virol. 2013 Feb 1;8(2):129-157. doi: 10.2217/fvl.12.130.
Magnus Pv, Andersen EK, Petersen KB, Birch-Andersen A. A POX-LIKE DISEASE IN CYNOMOLGUS MONKEYS. Acta Pathologica Microbiologica Scandinavica. 1959;46(2):156-76.
Kozlov M. Monkeypox in Africa: the science the world ignored. Nature. 2022 Jul;607(7917):17-18. doi: 10.1038/d41586-022-01686-z. No abstract available.
Tomori O, Blumberg L. Response to the multi-country monkeypox outbreak: a view from Africa. J Travel Med. 2022 Dec 27;29(8):taac138. doi: 10.1093/jtm/taac138. No abstract available.
Esposito JJ, Knight JC. Orthopoxvirus DNA: a comparison of restriction profiles and maps. Virology. 1985 May;143(1):230-51. doi: 10.1016/0042-6822(85)90111-4.
Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, Zhao H, Carroll DS, Curns A, Formenty P, Esposito JJ, Regnery RL, Damon IK. A tale of two clades: monkeypox viruses. J Gen Virol. 2005 Oct;86(Pt 10):2661-2672. doi: 10.1099/vir.0.81215-0.
Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. doi: 10.1371/journal.pntd.0010141. eCollection 2022 Feb.
Velavan TP, Meyer CG. Monkeypox 2022 outbreak: An update. Trop Med Int Health. 2022 Jul;27(7):604-605. doi: 10.1111/tmi.13785. Epub 2022 Jun 14. No abstract available.
Edouard Mathieu FS, Saloni Dattani, Hannah Ritchie and Max Roser
WHO. Multi-country outbreak of mpox, External situation report #19 - 30 March 2023 2023 [Available from: https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--19---30-march-2023.
Mitja O, Alemany A, Marks M, Lezama Mora JI, Rodriguez-Aldama JC, Torres Silva MS, Corral Herrera EA, Crabtree-Ramirez B, Blanco JL, Girometti N, Mazzotta V, Hazra A, Silva M, Montenegro-Idrogo JJ, Gebo K, Ghosn J, Pena Vazquez MF, Matos Prado E, Unigwe U, Villar-Garcia J, Wald-Dickler N, Zucker J, Paredes R, Calmy A, Waters L, Galvan-Casas C, Walmsley S, Orkin CM; SHARE-NET writing group. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023 Mar 18;401(10380):939-949. doi: 10.1016/S0140-6736(23)00273-8. Epub 2023 Feb 21. Erratum In: Lancet. 2023 Apr 8;401(10383):1158. doi: 10.1016/S0140-6736(23)00584-6.
Farahat RA, Abdelaal A, Shah J, Ghozy S, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, McHugh TD, Leblebicioglu H. Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? Ann Clin Microbiol Antimicrob. 2022 Jun 15;21(1):26. doi: 10.1186/s12941-022-00518-2. No abstract available.
Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005 Dec 15;41(12):1765-71. doi: 10.1086/498155. Epub 2005 Nov 11.
Yon H, Shin H, Shin JI, Shin JU, Shin YH, Lee J, Rhee SY, Koyanagi A, Jacob L, Smith L, Lee SW, Rahmati M, Ahmad S, Cho W, Yon DK. Clinical manifestations of human Mpox infection: A systematic review and meta-analysis. Rev Med Virol. 2023 Jul;33(4):e2446. doi: 10.1002/rmv.2446. Epub 2023 Apr 13.
WHO. Multi-country monkeypox outbreak: situation update; 27 June 2022 2022 [Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396.
Poland GA, Kennedy RB, Tosh PK. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis. 2022 Dec;22(12):e349-e358. doi: 10.1016/S1473-3099(22)00574-6. Epub 2022 Sep 15.
WHO. Laboratory testing for the monkeypox virus. Interim guidance 23 May 2022 2022 [Available from: https://www.who.int/publications-detail-redirect/WHO-MPX-laboratory-2022.1.
Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988 Sep;17(3):643-50. doi: 10.1093/ije/17.3.643.
Siegrist EA, Sassine J. Antivirals With Activity Against Mpox: A Clinically Oriented Review. Clin Infect Dis. 2023 Jan 6;76(1):155-164. doi: 10.1093/cid/ciac622.
WHO. Background document for the SAGE October 2022 session on monkeypox vaccines 2022 [Available from: https://www.who.int/publications/i/item/WHO-MPX-Immunization.
KM Biologics Co. L. Maximizing the Use of Freeze-Dried Smallpox Vaccine Prepared in Cell Culture LC16 "KMB" in Emergencies. 2023.
SOCIAL MDSYP. VIRUELA SIMICA; MONKEYPOX 2023 [Available from: https://app.powerbi.com/view?r=eyJrIjoiNjQzZGQ0ZjAtODRhMi00MzFhLWFmODctOWMxNGVkNGFjMDhkIiwidCI6ImE2MmQ2YzdiLTlmNTktNDQ2OS05MzU5LTM1MzcxNDc1OTRiYiIsImMiOjR9
WHO. Multi-country outbreak of mpox; External Situation Report, published 11 May 2023 2023 [Available from: https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--22---11-may-2023.
UNAIDS. AIDS HIV Estimate; Colombia [Available from: https://www.unaids.org/en/regionscountries/countries/colombia.
Cuenta de Alto Costo (CAC) FCdEdAC, Cuenta de Alto Costo (CAC). . Situación del VIH en Colombia 2022; Bogotá, D.C. 2023) [Available from: https://cuentadealtocosto.org/site/vih/vih-sida-en-colombia-retos-y-apuestas-en-salud/.
Johnson PLF, Bergstrom CT, Regoes RR, Longini IM, Halloran ME, Antia R. Evolutionary consequences of delaying intervention for monkeypox. Lancet. 2022 Oct 8;400(10359):1191-1193. doi: 10.1016/S0140-6736(22)01789-5. Epub 2022 Sep 21. No abstract available.
Morales-Zamora G, Espinosa O, Puertas E, Fernandez JC, Hernandez J, Zakzuk V, Cepeda M, Alvis-Guzman N, Castaneda-Orjuela C, Paternina-Caicedo A. Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan. Value Health Reg Issues. 2022 Sep;31:101-110. doi: 10.1016/j.vhri.2022.04.004. Epub 2022 May 26.
Kenner J, Cameron F, Empig C, Jobes DV, Gurwith M. LC16m8: an attenuated smallpox vaccine. Vaccine. 2006 Nov 17;24(47-48):7009-22. doi: 10.1016/j.vaccine.2006.03.087. Epub 2006 Apr 21.
Hirayama M. In search of attenuated vaccine. Clinical special edition: vaccination in future-everything about attenuated vaccine. Rinsho to Uirusu [Clin Virus]. 1975;3:225-8.
Hashizume S. Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain. Vaccinia Viruses as Vectors for Vaccine Antigens. 1985:87-99.
Hashizume S. Basics of New Attenuated Vaccine Strain LC16m8. Clinic and Virus ,1975 1975;Vol 3 No . 33:,229・35.
Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N, Hasegawa H, Ogata M, Fukushi S, Mizutani T, Sata T, Kurata T, Kurane I, Morikawa S. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. J Virol. 2006 Jun;80(11):5179-88. doi: 10.1128/JVI.02642-05.
Iizuka I, Ami Y, Suzaki Y, Nagata N, Fukushi S, Ogata M, Morikawa S, Hasegawa H, Mizuguchi M, Kurane I, Saijo M. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox. Jpn J Infect Dis. 2017 Jul 24;70(4):408-415. doi: 10.7883/yoken.JJID.2016.417. Epub 2016 Dec 22.
Gordon SN, Cecchinato V, Andresen V, Heraud JM, Hryniewicz A, Parks RW, Venzon D, Chung HK, Karpova T, McNally J, Silvera P, Reimann KA, Matsui H, Kanehara T, Shinmura Y, Yokote H, Franchini G. Smallpox vaccine safety is dependent on T cells and not B cells. J Infect Dis. 2011 Apr 15;203(8):1043-53. doi: 10.1093/infdis/jiq162.
Yokote H, Shinmura Y, Kanehara T, Maruno S, Kuranaga M, Matsui H, Hashizume S. Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice. Clin Vaccine Immunol. 2014 Sep;21(9):1261-6. doi: 10.1128/CVI.00199-14. Epub 2014 Jul 2.
Yokote H, Shinmura Y, Kanehara T, Maruno S, Kuranaga M, Matsui H, Hashizume S. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice. Vaccine. 2015 Nov 9;33(45):6112-9. doi: 10.1016/j.vaccine.2015.07.076. Epub 2015 Aug 1.
Yamaguchi M, Kimura M, Hirayama M. Vaccination research group research report: Ministry of Health and Welfare special research: postvaccination side effects and research regarding treatment of complications. Rinsho To Uirusu. 1975;3:269-79.
Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis. 2011 Nov;204(9):1395-402. doi: 10.1093/infdis/jir527. Epub 2011 Sep 15.
Pharmaceutical Safety and Environmental Health Bureau、Pharmaceutical Evaluation Division. Report on the Deliberation Results. 2022.
Nishiyama Y, Fujii T, Kanatani Y, Shinmura Y, Yokote H, Hashizume S. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice. Vaccine. 2015 Nov 9;33(45):6120-7. doi: 10.1016/j.vaccine.2015.09.067. Epub 2015 Oct 9.
Saito T, Fujii T, Kanatani Y, Saijo M, Morikawa S, Yokote H, Takeuchi T, Kuwabara N. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. JAMA. 2009 Mar 11;301(10):1025-33. doi: 10.1001/jama.2009.289.
Sanz-Munoz I, Sanchez-dePrada L, Sanchez-Martinez J, Rojo-Rello S, Dominguez-Gil M, Hernan-Garcia C, Fernandez-Espinilla V, de Lejarazu-Leonardo RO, Castrodeza-Sanz J, Eiros JM. Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults. Emerg Infect Dis. 2023 Mar;29(3):656-658. doi: 10.3201/eid2903.221231. Epub 2023 Feb 2.
Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care STDS. 2014 Aug;28(8):397-410. doi: 10.1089/apc.2014.0121. Epub 2014 Jul 16.
Overton ET, Stapleton J, Frank I, Hassler S, Goepfert PA, Barker D, Wagner E, von Krempelhuber A, Virgin G, Meyer TP, Muller J, Badeker N, Grunert R, Young P, Rosch S, Maclennan J, Arndtz-Wiedemann N, Chaplin P. Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial. Open Forum Infect Dis. 2015 May 5;2(2):ofv040. doi: 10.1093/ofid/ofv040. eCollection 2015 Apr. Erratum In: Open Forum Infect Dis. 2016 Feb 18;3(1):ofv183. doi: 10.1093/ofid/ofv183.
FDA. FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING VACCINE: EMERGENCY USE AUTHORIZATION OF JYNNEOS (SMALLPOX AND MONKEYPOX VACCINE, LIVE, NON-REPLICATING) FOR PREVENTION OF MONKEYPOX DISEASE IN INDIVIDUALS DETERMINED TO BE AT HIGH RISK FOR MONKEYPOX INFECTION 2022 [Available from: https://www.fda.gov/media/160774/download.
Geretti AM, Brook G, Cameron C, Chadwick D, French N, Heyderman R, Ho A, Hunter M, Ladhani S, Lawton M, MacMahon E, McSorley J, Pozniak A, Rodger A. British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015. HIV Med. 2016 Aug;17 Suppl 3:s2-s81. doi: 10.1111/hiv.12424. No abstract available.
Banaszkiewicz A, Radzikowski A. Efficacy, effectiveness, immunogenicity--are not the same in vaccinology. World J Gastroenterol. 2013 Nov 7;19(41):7217-8. doi: 10.3748/wjg.v19.i41.7217.
Curran KG, Eberly K, Russell OO, Snyder RE, Phillips EK, Tang EC, Peters PJ, Sanchez MA, Hsu L, Cohen SE, Sey EK, Yin S, Foo C, Still W, Mangla A, Saafir-Callaway B, Barrineau-Vejjajiva L, Meza C, Burkhardt E, Smith ME, Murphy PA, Kelly NK, Spencer H, Tabidze I, Pacilli M, Swain CA, Bogucki K, DelBarba C, Rajulu DT, Dailey A, Ricaldi J, Mena LA, Daskalakis D, Bachmann LH, Brooks JT, Oster AM; Monkeypox, HIV, and STI Team. HIV and Sexually Transmitted Infections Among Persons with Monkeypox - Eight U.S. Jurisdictions, May 17-July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1141-1147. doi: 10.15585/mmwr.mm7136a1.
WHO. Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022 2022 [Available from: https://www.who.int/publications/i/item/WHO-MPX-Immunization.
VIH PCd. Prep-Colombia.org [Available from: https://prep-colombia.org/como-funciona/.
WHO. Strategic Preparedness, Readiness and Response Plan, MONKEYPOX 2022 [Available from: https://www.who.int/publications/m/item/monkeypox-strategic-preparedness--readiness--and-response-plan-(sprp).
Social MdSyP. Guía de Práctica Clínica (GPC) basado en la evidencia científica para la atención de la infeccion por VIH/SIDA en personas adultas, gestantes y adolescentes (Clinical Practice Guideline based on scientific evidence for the care of HIV/AIDS infection in adults, pregnant women and adolescents) 2021 [Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/gpc-vih-adultos-2021.pdf.
Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, Martin JW, Muyembe JT. Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo. J Infect Dis. 2017 Oct 17;216(7):824-828. doi: 10.1093/infdis/jix260.
Reed JL, Scott DE, Bray M. Eczema vaccinatum. Clin Infect Dis. 2012 Mar;54(6):832-40. doi: 10.1093/cid/cir952. Epub 2012 Jan 30.
KMB. Package Insert: Freeze-dried Smallpox Vaccine Prepared in Cell Culture LC16m8 (KMB). 2022.
World Health Organization. WHO declares the end of the monkeypox emergency and calls for sustained efforts for the long-term management of the disease [Internet]. World Health Organization; May 2023 Available at: https://www.paho.org/es/noticias/11-5-2023-oms-declara-fin-emergency-por-viruela-simica-pide-esfuerzos-sostenidos-para
Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Konde MK, Keita S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Rottingen JA, Kieny MP. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Erratum In: Lancet. 2017 Feb 4;389(10068):504. doi: 10.1016/S0140-6736(16)32633-2. Lancet. 2017 Feb 4;389(10068):504. doi: 10.1016/S0140-6736(17)30210-6.
Hoffmann C, Jessen H, Wyen C, Grunwald S, Noe S, Teichmann J, Krauss AS, Kolarikal H, Scholten S, Schuler C, Bickel M, Roll C, Kreckel P, Koppe S, Straub M, Klausen G, Lenz J, Esser S, Jensen B, Rausch M, Unger S, Pauli R, Harter G, Muller M, Masuhr A, Schafer G, Seybold U, Schellberg S, Schneider J, Monin MB, Wolf E, Spinner CD, Boesecke C. Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany. HIV Med. 2023 Apr;24(4):389-397. doi: 10.1111/hiv.13378. Epub 2022 Sep 4.
EMA. Classification and analysis of the GCP inspection findings of GCP inspections conducted at the request of the CHM (Inspection reports to EMA 2000-2012) 2014 [updated 01 December 204. Available at: https://www.ema.europa.eu/en /documents/other/classification-analysis-good-clinical-practice-gcp-inspection-findings-gcp-inspections-conducted_en.pdf.
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009 Nov 10;28(25):3083-107. doi: 10.1002/sim.3697.
Austin PC, Small DS. The use of bootstrapping when using propensity-score matching without replacement: a simulation study. Stat Med. 2014 Oct 30;33(24):4306-19. doi: 10.1002/sim.6276. Epub 2014 Aug 4.
قاعدة البيانات: ClinicalTrials.gov
ResultId 1
Header edsclt
ClinicalTrials.gov
edsclt.NCT06223919
1082
2
Report
report
1082.24353027344
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsclt&AN=edsclt.NCT06223919&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://clinicaltrials.gov/study/NCT06223919 [Name] => EDS – ClinicalTrials.gov [Category] => fullText [Text] => View record in ClinicalTrials.gov [MouseOverText] => View record in ClinicalTrials.gov ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia (MPOX-COL) )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Ministerio+de+Salud+y+Protección+Social+de+Colombia%22">Ministerio de Salud y Protección Social de Colombia</searchLink><br /><searchLink fieldCode="AR" term="%22Ministry+of+Health%2C+Labour+and+Welfare%2C+Japan%22">Ministry of Health, Labour and Welfare, Japan</searchLink><br /><searchLink fieldCode="AR" term="%22Japan+Agency+for+Medical+Research+and+Development%22">Japan Agency for Medical Research and Development</searchLink><br /><searchLink fieldCode="AR" term="%22National+Center+for+Global+Health+and+Medicine%2C+Japan%22">National Center for Global Health and Medicine, Japan</searchLink><br /><searchLink fieldCode="AR" term="%22National+Institute+of+Infectious+Disease%2C+Japan%22">National Institute of Infectious Disease, Japan</searchLink><br /><searchLink fieldCode="AR" term="%22Instituto+Nacional+de+Salud%22">Instituto Nacional de Salud</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Randomized Trial to Evaluate the Efficacy/Effectiveness, Safety, and Immunogenicity of Replicative Live Attenuated Vaccinia Virus Vaccine LC16m8 for Prevention Against Mpox in High-risk Populations During Vaccination Deployment in Colombia<br />Adnan N, Haq ZU, Malik A, Mehmood A, Ishaq U, Faraz M, Malik J, Mehmoodi A. Human monkeypox virus: An updated review. Medicine (Baltimore). 2022 Sep 2;101(35):e30406. doi: 10.1097/MD.0000000000030406.<br />Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, Smajlovic S, Cordic S, Rabaan AA, Alsuhaimi E. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023 Apr;16(4):531-541. doi: 10.1016/j.jiph.2023.02.003. Epub 2023 Feb 9.<br />Mitja O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, Orkin CM. Monkeypox. Lancet. 2023 Jan 7;401(10370):60-74. doi: 10.1016/S0140-6736(22)02075-X. Epub 2022 Nov 17. Erratum In: Lancet. 2022 Dec 3;400(10367):1926. doi: 10.1016/S0140-6736(22)02414-X.<br />Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004 Jan;4(1):15-25. doi: 10.1016/s1473-3099(03)00856-9. Erratum In: Lancet Infect Dis. 2004 Apr;4(4):251.<br />Shchelkunov SN, Marennikova SS, Moyer RW. Orthopoxviruses pathogenic for humans: Springer Science & Business Media; 2006.<br />McInnes et al. Family: Poxviridae [Website]. International Committee on Taxonomy of Viruses (ICTV); 2023 [updated 2023/04/17.<br />Parker S, Buller RM. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Future Virol. 2013 Feb 1;8(2):129-157. doi: 10.2217/fvl.12.130.<br />Magnus Pv, Andersen EK, Petersen KB, Birch-Andersen A. A POX-LIKE DISEASE IN CYNOMOLGUS MONKEYS. Acta Pathologica Microbiologica Scandinavica. 1959;46(2):156-76.<br />Kozlov M. Monkeypox in Africa: the science the world ignored. Nature. 2022 Jul;607(7917):17-18. doi: 10.1038/d41586-022-01686-z. No abstract available.<br />Tomori O, Blumberg L. Response to the multi-country monkeypox outbreak: a view from Africa. J Travel Med. 2022 Dec 27;29(8):taac138. doi: 10.1093/jtm/taac138. No abstract available.<br />Esposito JJ, Knight JC. Orthopoxvirus DNA: a comparison of restriction profiles and maps. Virology. 1985 May;143(1):230-51. doi: 10.1016/0042-6822(85)90111-4.<br />Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, Zhao H, Carroll DS, Curns A, Formenty P, Esposito JJ, Regnery RL, Damon IK. A tale of two clades: monkeypox viruses. J Gen Virol. 2005 Oct;86(Pt 10):2661-2672. doi: 10.1099/vir.0.81215-0.<br />Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. doi: 10.1371/journal.pntd.0010141. eCollection 2022 Feb.<br />Velavan TP, Meyer CG. Monkeypox 2022 outbreak: An update. Trop Med Int Health. 2022 Jul;27(7):604-605. doi: 10.1111/tmi.13785. Epub 2022 Jun 14. No abstract available.<br />Edouard Mathieu FS, Saloni Dattani, Hannah Ritchie and Max Roser<br />WHO. Multi-country outbreak of mpox, External situation report #19 - 30 March 2023 2023 [Available from: https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--19---30-march-2023.<br />Mitja O, Alemany A, Marks M, Lezama Mora JI, Rodriguez-Aldama JC, Torres Silva MS, Corral Herrera EA, Crabtree-Ramirez B, Blanco JL, Girometti N, Mazzotta V, Hazra A, Silva M, Montenegro-Idrogo JJ, Gebo K, Ghosn J, Pena Vazquez MF, Matos Prado E, Unigwe U, Villar-Garcia J, Wald-Dickler N, Zucker J, Paredes R, Calmy A, Waters L, Galvan-Casas C, Walmsley S, Orkin CM; SHARE-NET writing group. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023 Mar 18;401(10380):939-949. doi: 10.1016/S0140-6736(23)00273-8. Epub 2023 Feb 21. Erratum In: Lancet. 2023 Apr 8;401(10383):1158. doi: 10.1016/S0140-6736(23)00584-6.<br />Farahat RA, Abdelaal A, Shah J, Ghozy S, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, McHugh TD, Leblebicioglu H. Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? Ann Clin Microbiol Antimicrob. 2022 Jun 15;21(1):26. doi: 10.1186/s12941-022-00518-2. No abstract available.<br />Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005 Dec 15;41(12):1765-71. doi: 10.1086/498155. Epub 2005 Nov 11.<br />Yon H, Shin H, Shin JI, Shin JU, Shin YH, Lee J, Rhee SY, Koyanagi A, Jacob L, Smith L, Lee SW, Rahmati M, Ahmad S, Cho W, Yon DK. Clinical manifestations of human Mpox infection: A systematic review and meta-analysis. Rev Med Virol. 2023 Jul;33(4):e2446. doi: 10.1002/rmv.2446. Epub 2023 Apr 13.<br />WHO. Multi-country monkeypox outbreak: situation update; 27 June 2022 2022 [Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396.<br />Poland GA, Kennedy RB, Tosh PK. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis. 2022 Dec;22(12):e349-e358. doi: 10.1016/S1473-3099(22)00574-6. Epub 2022 Sep 15.<br />WHO. Laboratory testing for the monkeypox virus. Interim guidance 23 May 2022 2022 [Available from: https://www.who.int/publications-detail-redirect/WHO-MPX-laboratory-2022.1.<br />Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988 Sep;17(3):643-50. doi: 10.1093/ije/17.3.643.<br />Siegrist EA, Sassine J. Antivirals With Activity Against Mpox: A Clinically Oriented Review. Clin Infect Dis. 2023 Jan 6;76(1):155-164. doi: 10.1093/cid/ciac622.<br />WHO. Background document for the SAGE October 2022 session on monkeypox vaccines 2022 [Available from: https://www.who.int/publications/i/item/WHO-MPX-Immunization.<br />KM Biologics Co. L. Maximizing the Use of Freeze-Dried Smallpox Vaccine Prepared in Cell Culture LC16 "KMB" in Emergencies. 2023.<br />SOCIAL MDSYP. VIRUELA SIMICA; MONKEYPOX 2023 [Available from: https://app.powerbi.com/view?r=eyJrIjoiNjQzZGQ0ZjAtODRhMi00MzFhLWFmODctOWMxNGVkNGFjMDhkIiwidCI6ImE2MmQ2YzdiLTlmNTktNDQ2OS05MzU5LTM1MzcxNDc1OTRiYiIsImMiOjR9<br />WHO. Multi-country outbreak of mpox; External Situation Report, published 11 May 2023 2023 [Available from: https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--22---11-may-2023.<br />UNAIDS. AIDS HIV Estimate; Colombia [Available from: https://www.unaids.org/en/regionscountries/countries/colombia.<br />Cuenta de Alto Costo (CAC) FCdEdAC, Cuenta de Alto Costo (CAC). . Situación del VIH en Colombia 2022; Bogotá, D.C. 2023) [Available from: https://cuentadealtocosto.org/site/vih/vih-sida-en-colombia-retos-y-apuestas-en-salud/.<br />Johnson PLF, Bergstrom CT, Regoes RR, Longini IM, Halloran ME, Antia R. Evolutionary consequences of delaying intervention for monkeypox. Lancet. 2022 Oct 8;400(10359):1191-1193. doi: 10.1016/S0140-6736(22)01789-5. Epub 2022 Sep 21. No abstract available.<br />Morales-Zamora G, Espinosa O, Puertas E, Fernandez JC, Hernandez J, Zakzuk V, Cepeda M, Alvis-Guzman N, Castaneda-Orjuela C, Paternina-Caicedo A. Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan. Value Health Reg Issues. 2022 Sep;31:101-110. doi: 10.1016/j.vhri.2022.04.004. Epub 2022 May 26.<br />Kenner J, Cameron F, Empig C, Jobes DV, Gurwith M. LC16m8: an attenuated smallpox vaccine. Vaccine. 2006 Nov 17;24(47-48):7009-22. doi: 10.1016/j.vaccine.2006.03.087. Epub 2006 Apr 21.<br />Hirayama M. In search of attenuated vaccine. Clinical special edition: vaccination in future-everything about attenuated vaccine. Rinsho to Uirusu [Clin Virus]. 1975;3:225-8.<br />Hashizume S. Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain. Vaccinia Viruses as Vectors for Vaccine Antigens. 1985:87-99.<br />Hashizume S. Basics of New Attenuated Vaccine Strain LC16m8. Clinic and Virus ,1975 1975;Vol 3 No . 33:,229・35.<br />Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N, Hasegawa H, Ogata M, Fukushi S, Mizutani T, Sata T, Kurata T, Kurane I, Morikawa S. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. J Virol. 2006 Jun;80(11):5179-88. doi: 10.1128/JVI.02642-05.<br />Iizuka I, Ami Y, Suzaki Y, Nagata N, Fukushi S, Ogata M, Morikawa S, Hasegawa H, Mizuguchi M, Kurane I, Saijo M. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox. Jpn J Infect Dis. 2017 Jul 24;70(4):408-415. doi: 10.7883/yoken.JJID.2016.417. Epub 2016 Dec 22.<br />Gordon SN, Cecchinato V, Andresen V, Heraud JM, Hryniewicz A, Parks RW, Venzon D, Chung HK, Karpova T, McNally J, Silvera P, Reimann KA, Matsui H, Kanehara T, Shinmura Y, Yokote H, Franchini G. Smallpox vaccine safety is dependent on T cells and not B cells. J Infect Dis. 2011 Apr 15;203(8):1043-53. doi: 10.1093/infdis/jiq162.<br />Yokote H, Shinmura Y, Kanehara T, Maruno S, Kuranaga M, Matsui H, Hashizume S. Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice. Clin Vaccine Immunol. 2014 Sep;21(9):1261-6. doi: 10.1128/CVI.00199-14. Epub 2014 Jul 2.<br />Yokote H, Shinmura Y, Kanehara T, Maruno S, Kuranaga M, Matsui H, Hashizume S. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice. Vaccine. 2015 Nov 9;33(45):6112-9. doi: 10.1016/j.vaccine.2015.07.076. Epub 2015 Aug 1.<br />Yamaguchi M, Kimura M, Hirayama M. Vaccination research group research report: Ministry of Health and Welfare special research: postvaccination side effects and research regarding treatment of complications. Rinsho To Uirusu. 1975;3:269-79.<br />Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis. 2011 Nov;204(9):1395-402. doi: 10.1093/infdis/jir527. Epub 2011 Sep 15.<br />Pharmaceutical Safety and Environmental Health Bureau、Pharmaceutical Evaluation Division. Report on the Deliberation Results. 2022.<br />Nishiyama Y, Fujii T, Kanatani Y, Shinmura Y, Yokote H, Hashizume S. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice. Vaccine. 2015 Nov 9;33(45):6120-7. doi: 10.1016/j.vaccine.2015.09.067. Epub 2015 Oct 9.<br />Saito T, Fujii T, Kanatani Y, Saijo M, Morikawa S, Yokote H, Takeuchi T, Kuwabara N. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. JAMA. 2009 Mar 11;301(10):1025-33. doi: 10.1001/jama.2009.289.<br />Sanz-Munoz I, Sanchez-dePrada L, Sanchez-Martinez J, Rojo-Rello S, Dominguez-Gil M, Hernan-Garcia C, Fernandez-Espinilla V, de Lejarazu-Leonardo RO, Castrodeza-Sanz J, Eiros JM. Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults. Emerg Infect Dis. 2023 Mar;29(3):656-658. doi: 10.3201/eid2903.221231. Epub 2023 Feb 2.<br />Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care STDS. 2014 Aug;28(8):397-410. doi: 10.1089/apc.2014.0121. Epub 2014 Jul 16.<br />Overton ET, Stapleton J, Frank I, Hassler S, Goepfert PA, Barker D, Wagner E, von Krempelhuber A, Virgin G, Meyer TP, Muller J, Badeker N, Grunert R, Young P, Rosch S, Maclennan J, Arndtz-Wiedemann N, Chaplin P. Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial. Open Forum Infect Dis. 2015 May 5;2(2):ofv040. doi: 10.1093/ofid/ofv040. eCollection 2015 Apr. Erratum In: Open Forum Infect Dis. 2016 Feb 18;3(1):ofv183. doi: 10.1093/ofid/ofv183.<br />FDA. FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING VACCINE: EMERGENCY USE AUTHORIZATION OF JYNNEOS (SMALLPOX AND MONKEYPOX VACCINE, LIVE, NON-REPLICATING) FOR PREVENTION OF MONKEYPOX DISEASE IN INDIVIDUALS DETERMINED TO BE AT HIGH RISK FOR MONKEYPOX INFECTION 2022 [Available from: https://www.fda.gov/media/160774/download.<br />Geretti AM, Brook G, Cameron C, Chadwick D, French N, Heyderman R, Ho A, Hunter M, Ladhani S, Lawton M, MacMahon E, McSorley J, Pozniak A, Rodger A. British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015. HIV Med. 2016 Aug;17 Suppl 3:s2-s81. doi: 10.1111/hiv.12424. No abstract available.<br />Banaszkiewicz A, Radzikowski A. Efficacy, effectiveness, immunogenicity--are not the same in vaccinology. World J Gastroenterol. 2013 Nov 7;19(41):7217-8. doi: 10.3748/wjg.v19.i41.7217.<br />Curran KG, Eberly K, Russell OO, Snyder RE, Phillips EK, Tang EC, Peters PJ, Sanchez MA, Hsu L, Cohen SE, Sey EK, Yin S, Foo C, Still W, Mangla A, Saafir-Callaway B, Barrineau-Vejjajiva L, Meza C, Burkhardt E, Smith ME, Murphy PA, Kelly NK, Spencer H, Tabidze I, Pacilli M, Swain CA, Bogucki K, DelBarba C, Rajulu DT, Dailey A, Ricaldi J, Mena LA, Daskalakis D, Bachmann LH, Brooks JT, Oster AM; Monkeypox, HIV, and STI Team. HIV and Sexually Transmitted Infections Among Persons with Monkeypox - Eight U.S. Jurisdictions, May 17-July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1141-1147. doi: 10.15585/mmwr.mm7136a1.<br />WHO. Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022 2022 [Available from: https://www.who.int/publications/i/item/WHO-MPX-Immunization.<br />VIH PCd. Prep-Colombia.org [Available from: https://prep-colombia.org/como-funciona/.<br />WHO. Strategic Preparedness, Readiness and Response Plan, MONKEYPOX 2022 [Available from: https://www.who.int/publications/m/item/monkeypox-strategic-preparedness--readiness--and-response-plan-(sprp).<br />Social MdSyP. Guía de Práctica Clínica (GPC) basado en la evidencia científica para la atención de la infeccion por VIH/SIDA en personas adultas, gestantes y adolescentes (Clinical Practice Guideline based on scientific evidence for the care of HIV/AIDS infection in adults, pregnant women and adolescents) 2021 [Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/gpc-vih-adultos-2021.pdf.<br />Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, Martin JW, Muyembe JT. Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo. J Infect Dis. 2017 Oct 17;216(7):824-828. doi: 10.1093/infdis/jix260.<br />Reed JL, Scott DE, Bray M. Eczema vaccinatum. Clin Infect Dis. 2012 Mar;54(6):832-40. doi: 10.1093/cid/cir952. Epub 2012 Jan 30.<br />KMB. Package Insert: Freeze-dried Smallpox Vaccine Prepared in Cell Culture LC16m8 (KMB). 2022.<br />World Health Organization. WHO declares the end of the monkeypox emergency and calls for sustained efforts for the long-term management of the disease [Internet]. World Health Organization; May 2023 Available at: https://www.paho.org/es/noticias/11-5-2023-oms-declara-fin-emergency-por-viruela-simica-pide-esfuerzos-sostenidos-para<br />Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Konde MK, Keita S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Rottingen JA, Kieny MP. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Erratum In: Lancet. 2017 Feb 4;389(10068):504. doi: 10.1016/S0140-6736(16)32633-2. Lancet. 2017 Feb 4;389(10068):504. doi: 10.1016/S0140-6736(17)30210-6.<br />Hoffmann C, Jessen H, Wyen C, Grunwald S, Noe S, Teichmann J, Krauss AS, Kolarikal H, Scholten S, Schuler C, Bickel M, Roll C, Kreckel P, Koppe S, Straub M, Klausen G, Lenz J, Esser S, Jensen B, Rausch M, Unger S, Pauli R, Harter G, Muller M, Masuhr A, Schafer G, Seybold U, Schellberg S, Schneider J, Monin MB, Wolf E, Spinner CD, Boesecke C. Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany. HIV Med. 2023 Apr;24(4):389-397. doi: 10.1111/hiv.13378. Epub 2022 Sep 4.<br />EMA. Classification and analysis of the GCP inspection findings of GCP inspections conducted at the request of the CHM (Inspection reports to EMA 2000-2012) 2014 [updated 01 December 204. Available at: https://www.ema.europa.eu/en /documents/other/classification-analysis-good-clinical-practice-gcp-inspection-findings-gcp-inspections-conducted_en.pdf.<br />Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009 Nov 10;28(25):3083-107. doi: 10.1002/sim.3697.<br />Austin PC, Small DS. The use of bootstrapping when using propensity-score matching without replacement: a simulation study. Stat Med. 2014 Oct 30;33(24):4306-19. doi: 10.1002/sim.6276. Epub 2014 Aug 4. )
RecordInfo Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia (MPOX-COL) [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ministerio de Salud y Protección Social de Colombia ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ministry of Health, Labour and Welfare, Japan ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Japan Agency for Medical Research and Development ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => National Center for Global Health and Medicine, Japan ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => National Institute of Infectious Disease, Japan ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Instituto Nacional de Salud ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 13 [M] => 08 [Type] => published [Y] => 2024 ) ) ) ) ) ) )
IllustrationInfo